Novoheart Named 2020 Venture 50 Company Ranked Among Year’s Top Performing Stocks in Life Sciences
Novoheart is pleased to announce that it has been named a 2020 Venture 50 Company, ranked among the TSX Venture Exchange’s top 50 best performing companies.
The ranking comprises ten companies from each of five key industry sectors. Novoheart is one of the ten best performers within the Clean Technology and Life Sciences sector.
Ranking was based on three equally weighted criteria:
- Share price: one-year share price change as of December 31, 2019
- Trading: one-year trading volume as of December 31, 2019
- Market capitalization: one-year market capitalization change as of December 31, 2019
For more detailed press release, please click here.